Table 4.
Analysis of In-hospital outcomes in VA patients (VT/VF vs. Non-VT/VF)
| All (n = 359) | VT/VF (n = 95) | Non-VT/VF (n = 264) | P value | |
|---|---|---|---|---|
| In-hospital MACE, n (%) | 54 (15.0%) | 24 (25.3%) | 30 (11.4%) | < 0.001 |
| Cardiac death, n (%) | 14 (3.9%) | 8 (8.4%) | 6 (2.3%) | 0.012 |
| MI, n (%) | 48 (13.4%) | 22 (23.2%) | 26 (9.8%) | 0.002 |
| TVR, n (%) | 33 (9.2%) | 14 (14.7%) | 19 (7.2%) | 0.029 |
| Acute stent thrombosis, n (%) | 3 (0.8%) | 1 (1.1%) | 2 (0.8%) | 0.763 |
Categorical variables were expressed as number (percentage)
VA Ventricular arrhythmia, VT Ventricular tachycardia, VF Ventricular fibrillation, MACE Major adverse cardiovascular event, TVR Target-vessel revascularization, MI Myocardial infarction